BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20812330)

  • 1. Short pediatric Crohn's disease activity index for quality improvement and observational research.
    Kappelman MD; Crandall WV; Colletti RB; Goudie A; Leibowitz IH; Duffy L; Milov DE; Kim SC; Schoen BT; Patel AS; Grunow J; Larry E; Fairbrother G; Margolis P
    Inflamm Bowel Dis; 2011 Jan; 17(1):112-7. PubMed ID: 20812330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical weighting of the pediatric Crohn's disease activity index (PCDAI) and comparison with its other short versions.
    Turner D; Griffiths AM; Walters TD; Seah T; Markowitz J; Pfefferkorn M; Keljo D; Waxman J; Otley A; LeLeiko NS; Mack D; Hyams J; Levine A
    Inflamm Bowel Dis; 2012 Jan; 18(1):55-62. PubMed ID: 21351206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is an abbreviated Pediatric Crohn's Disease Activity Index better than the original?
    Shepanski MA; Markowitz JE; Mamula P; Hurd LB; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):68-72. PubMed ID: 15187784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which PCDAI Version Best Reflects Intestinal Inflammation in Pediatric Crohn Disease?
    Turner D; Levine A; Walters TD; Focht G; Otley A; López VN; Koletzko S; Baldassano R; Mack D; Hyams J; Griffiths AM
    J Pediatr Gastroenterol Nutr; 2017 Feb; 64(2):254-260. PubMed ID: 27050050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric Crohn Disease Activity Index: responsive to short-term change.
    Kundhal PS; Critch JN; Zachos M; Otley AR; Stephens D; Griffiths AM
    J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):83-9. PubMed ID: 12500001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a pediatric Crohn's disease activity index.
    Hyams JS; Ferry GD; Mandel FS; Gryboski JD; Kibort PM; Kirschner BS; Griffiths AM; Katz AJ; Grand RJ; Boyle JT
    J Pediatr Gastroenterol Nutr; 1991 May; 12(4):439-47. PubMed ID: 1678008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing disease activity using the pediatric Crohn's disease activity index: Can we use subjective or objective parameters alone?
    Grant A; Lerer T; Griffiths AM; Hyams JS; Otley A
    World J Gastroenterol; 2021 Aug; 27(30):5100-5111. PubMed ID: 34497438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.
    Hyams J; Markowitz J; Otley A; Rosh J; Mack D; Bousvaros A; Kugathasan S; Pfefferkorn M; Tolia V; Evans J; Treem W; Wyllie R; Rothbaum R; del Rosario J; Katz A; Mezoff A; Oliva-Hemker M; Lerer T; Griffiths A;
    J Pediatr Gastroenterol Nutr; 2005 Oct; 41(4):416-21. PubMed ID: 16205508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease.
    Hijaz NM; Attard TM; Colombo JM; Mardis NJ; Friesen CA
    World J Gastroenterol; 2019 Jul; 25(28):3808-3822. PubMed ID: 31391775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing activity of pediatric Crohn's disease: which index to use?
    Otley A; Loonen H; Parekh N; Corey M; Sherman PM; Griffiths AM
    Gastroenterology; 1999 Mar; 116(3):527-31. PubMed ID: 10029610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical assessment of items on the Pediatric Crohn's Disease Activity Index.
    Loonen HJ; Griffiths AM; Merkus MP; Derkx HH
    J Pediatr Gastroenterol Nutr; 2003 Jan; 36(1):90-5. PubMed ID: 12500002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor Concordance Between Clinical Activity and Endoscopic Severity in Pediatric Crohn's Disease: Before and After Induction Therapy.
    Yu Y; Zhao H; Luo Y; Lou J; Chen J; Fang Y
    Dig Dis Sci; 2022 Mar; 67(3):997-1006. PubMed ID: 33818661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Zubin G; Peter L
    Inflamm Bowel Dis; 2015 Jun; 21(6):1386-91. PubMed ID: 25851564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraintestinal manifestation of inflammatory bowel disease and associated factors in pediatric patients.
    Rahmani P; Rasti G; Gorgi M; Motamed F; Sharifi P
    Ann Med Surg (Lond); 2022 Mar; 75():103363. PubMed ID: 35242319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint involvement, disease activity and quality of life in pediatric Crohn's disease - a cross-sectional study.
    Derfalvi B; Boros KK; Szabo D; Bozsaki G; Cseh A; Rudas G; Muller KE; Veres G
    Pediatr Rheumatol Online J; 2022 Jan; 20(1):6. PubMed ID: 35093127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing pediatric ileocolonic Crohn's disease activity based on global MR enterography scores.
    Pomerri F; Al Bunni F; Zuliani M; Guariso G; Gasparetto M; Giorgi B; Cananzi M; Muzzio PC
    Eur Radiol; 2017 Mar; 27(3):1044-1051. PubMed ID: 27277259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control.
    van Rheenen PF
    Inflamm Bowel Dis; 2012 Nov; 18(11):2018-25. PubMed ID: 22275341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.
    Szabó D; Kökönyei G; Arató A; Dezsőfi A; Molnár K; Müller KE; Lakatos PL; Papp M; Lovász BD; Golovics PA; Cseh A; Veres G
    J Crohns Colitis; 2014 Aug; 8(8):747-55. PubMed ID: 24434181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.